News

The first patient with hantavirus in Spain is discharged

The first patient diagnosed with hantavirus in Spain has been medically discharged after overcoming the illness. The 70-year-old man tested negative in two consecutive PCR tests and had been symptom-free for three days, allowing his hospital admission to be concluded.

The recovery comes as a relief during a health episode that is unusual in Spain. Although the case has attracted public attention, doctors are continuing to monitor the patient, who will remain under observation for the next six months to rule out complications.

Discharge does not mean the protocol is over. For rare infectious diseases, follow-up is an important part of the process, especially for older patients or those who have required isolation and specialised monitoring.

Meanwhile, another patient with a confirmed hantavirus diagnosis remains hospitalised in Madrid. Their condition is stable and symptoms are mild, but medical teams are keeping them under observation to monitor for any changes.

The case is linked to the health alert triggered after travellers returned from an at-risk environment. The hospital response has made it possible to isolate the patients, carry out regular tests, and also monitor other possible contacts.

Hantavirus is a rare disease in Spain and is mainly transmitted through contact with infected rodents or their secretions. It can start with flu-like symptoms, although in some cases it can become more serious and affect the body more severely.

For Madrid, the news has a practical meaning: there are no signs of general risk to the population, but it is an example of how protocols are activated when an uncommon infection appears. The key is early detection, isolating when necessary, and monitoring patients until full recovery is confirmed.

For those with relatives in hospital or who work in healthcare settings, the discharge of the first patient brings reassurance. The episode remains under medical control and the second case continues to be monitored, but the progress of the first patient shows that the protocol is working.